Gilead plans to consolidate R&D at California site

06/25/2010 | News & Observer (Raleigh, N.C.), The

Gilead Sciences announced that it will let go of 150 employees by the end of the year as a result of closing down its research-and-development unit in Durham, N.C. The biotech firm will transfer about 30 of the workers to Foster City, Calif., where it will consolidate R&D programs for hepatitis B and C treatments.

View Full Article in:

News & Observer (Raleigh, N.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL